Skip to main content
Beta Drugs Limited logo

Beta Drugs Limited — Investor Relations & Filings

Ticker · BETA ISIN · INE351Y01019 LEI · 984500A89888DB9E6T57 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 431 across all filing types
Latest filing 2024-12-21 Declaration of Voting R…
Country IN India
Listing National Stock Exchange of India BETA

About Beta Drugs Limited

https://www.betadrugslimited.com

Beta Drugs Limited specializes in the development, manufacture, and marketing of oncology formulations. The company provides a comprehensive portfolio of anti-cancer drugs across various therapeutic segments, including cytotoxic injectables, lyophilized products, tablets, and capsules. Its manufacturing capabilities encompass a wide range of oncology treatments such as chemotherapy agents and supportive care medications. The organization operates advanced production facilities designed to meet international quality standards, focusing on high-potency active pharmaceutical ingredients and finished dosage forms. The company serves diverse markets through its own branded products and contract manufacturing services, aiming to provide affordable and high-quality cancer care solutions. Its core competency lies in its specialized focus on the oncology niche and its integrated approach to pharmaceutical production.

Recent filings

Filing Released Lang Actions
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed summary of the proceedings of an Extra Ordinary General Meeting (EGM) held on December 21, 2024. It includes information about the meeting's agenda, voting procedures (e-voting and poll), appointment of directors, adoption of restated Articles of Association, and the conduct and conclusion of the meeting. It also mentions the announcement of voting results to be made available later. The document is not the actual voting results declaration but a summary of the meeting proceedings. It is not a full financial report, audit report, or earnings release. It is not a proxy solicitation or a report publication announcement. The content fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) as it relates to the official summary and conduct of voting at a general meeting, even though the final consolidated results are to be announced later. The document is more than 5,000 characters and contains substantive details about the meeting and voting process, not just a brief notice or announcement. Therefore, the best classification is DVA.
2024-12-21 English
Reply to Clarification- Financial results
Regulatory Filings
2024-12-19 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Limited regarding the publication of a newspaper advertisement for an Extraordinary General Meeting (EGM) scheduled for December 21, 2024. It includes information about the notice being published in newspapers and is intended for information and record purposes. The document is short (1029 characters) and does not contain any financial data, detailed meeting materials, voting results, or management information. It is an announcement about the publication of the EGM notice rather than the notice itself or any meeting materials. Therefore, it fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-11-28 English
Shareholders meeting
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Notice of Extraordinary General Meeting (EGM) for Beta Drugs Limited, dated November 27, 2024, with the meeting scheduled for December 21, 2024. It includes details about the agenda items such as adoption of restated articles of association and appointment of directors, voting instructions, proxy information, and procedural notes. There are no financial statements or financial performance data included. The document is a formal notice sent to shareholders to convene the EGM and solicit their participation and votes. This fits the definition of Proxy Solicitation & Information Statement (PSI), as it provides information to shareholders to request their votes for the meeting. It is not an announcement of voting results, nor a management report or annual/interim report. Therefore, the correct classification is PSI with high confidence.
2024-11-27 English
Outcome of Board Meeting
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to the National Stock Exchange of India regarding disclosures and outcomes of a board meeting of Beta Drugs Limited. It references Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements, which pertains to disclosure of material events to stock exchanges. The document details several board decisions including allotment of shares and convertible debentures, alteration of articles of association, appointment of two additional directors, and convening an extraordinary general meeting. The content focuses on announcements of board decisions and appointments rather than detailed financial data or full reports. The document length is 8072 characters, which is substantial but the content is clearly an announcement of board meeting outcomes and related disclosures, not a full annual or interim report, audit report, or earnings release. It also includes detailed information about director appointments, which fits the category of Board/Management Information. Therefore, the most appropriate classification is MANG (Board/Management Information).
2024-11-27 English
Updates
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to the National Stock Exchange of India Limited, notifying about a forthcoming Board Meeting scheduled for 27th November 2024. The agenda includes approval of allotment of equity shares and convertible debentures, and adoption of restated Articles of Association. This is a notification of a board meeting and its agenda, not a report or financial statement. It does not contain financial results or detailed analysis, nor is it a voting result or a regulatory compliance filing. The content fits best under Board/Management Information as it relates to board meeting scheduling and agenda disclosure.
2024-11-22 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.